annual EBITDA:
$69.95M+$77.65M(+1008.05%)Summary
- As of today (June 2, 2025), TMDX annual EBITDA is $69.95 million, with the most recent change of +$77.65 million (+1008.05%) on December 31, 2024.
- During the last 3 years, TMDX annual EBITDA has risen by +$108.44 million (+281.74%).
- TMDX annual EBITDA is now at all-time high.
Performance
TMDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$36.27M+$20.03M(+123.36%)Summary
- As of today (June 2, 2025), TMDX quarterly EBITDA is $36.27 million, with the most recent change of +$20.03 million (+123.36%) on March 31, 2025.
- Over the past year, TMDX quarterly EBITDA has increased by +$15.98 million (+78.75%).
- TMDX quarterly EBITDA is now at all-time high.
Performance
TMDX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$85.93M+$15.98M(+22.85%)Summary
- As of today (June 2, 2025), TMDX TTM EBITDA is $85.93 million, with the most recent change of +$15.98 million (+22.85%) on March 31, 2025.
- Over the past year, TMDX TTM EBITDA has increased by +$73.09 million (+569.38%).
- TMDX TTM EBITDA is now at all-time high.
Performance
TMDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TMDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1008.0% | +78.8% | +569.4% |
| 3 y3 years | +281.7% | +499.1% | +309.3% |
| 5 y5 years | +350.4% | +588.3% | +388.2% |
TMDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +281.7% | at high | +269.1% | at high | +306.8% |
| 5 y | 5-year | at high | +281.7% | at high | +269.1% | at high | +306.8% |
| alltime | all time | at high | +281.7% | at high | +269.1% | at high | +306.8% |
TMDX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $36.27M(+123.4%) | $85.93M(+22.8%) |
| Dec 2024 | $69.95M(-1008.0%) | $16.24M(+24.5%) | $69.95M(+8.0%) |
| Sep 2024 | - | $13.04M(-36.0%) | $64.78M(+113.8%) |
| Jun 2024 | - | $20.38M(+0.4%) | $30.30M(+136.0%) |
| Mar 2024 | - | $20.29M(+83.3%) | $12.84M(-266.6%) |
| Dec 2023 | -$7.70M(-73.4%) | $11.07M(-151.6%) | -$7.70M(-66.8%) |
| Sep 2023 | - | -$21.45M(-835.2%) | -$23.18M(+210.5%) |
| Jun 2023 | - | $2.92M(-1281.0%) | -$7.47M(-62.9%) |
| Mar 2023 | - | -$247.00K(-94.4%) | -$20.12M(-30.5%) |
| Dec 2022 | -$28.96M(-24.8%) | -$4.41M(-23.0%) | -$28.96M(-19.0%) |
| Sep 2022 | - | -$5.73M(-41.1%) | -$35.76M(-13.9%) |
| Jun 2022 | - | -$9.73M(+7.1%) | -$41.55M(+1.2%) |
| Mar 2022 | - | -$9.09M(-18.9%) | -$41.06M(+6.7%) |
| Dec 2021 | -$38.49M | -$11.21M(-2.7%) | -$38.49M(+19.6%) |
| Sep 2021 | - | -$11.52M(+24.6%) | -$32.18M(+32.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$9.25M(+41.9%) | -$24.37M(+9.6%) |
| Mar 2021 | - | -$6.52M(+33.0%) | -$22.24M(-3.9%) |
| Dec 2020 | -$23.15M(-17.1%) | -$4.90M(+32.1%) | -$23.15M(-11.0%) |
| Sep 2020 | - | -$3.71M(-47.9%) | -$26.00M(-10.8%) |
| Jun 2020 | - | -$7.12M(-4.2%) | -$29.15M(-2.2%) |
| Mar 2020 | - | -$7.43M(-4.1%) | -$29.81M(+6.7%) |
| Dec 2019 | -$27.93M(+38.1%) | -$7.75M(+13.0%) | -$27.93M(+5.4%) |
| Sep 2019 | - | -$6.85M(-11.9%) | -$26.51M(+13.0%) |
| Jun 2019 | - | -$7.78M(+40.3%) | -$23.46M(+10.1%) |
| Mar 2019 | - | -$5.55M(-12.3%) | -$21.30M(+5.3%) |
| Dec 2018 | -$20.23M(+6.0%) | -$6.33M(+66.1%) | -$20.23M(+45.5%) |
| Sep 2018 | - | -$3.81M(-32.3%) | -$13.90M(+37.7%) |
| Jun 2018 | - | -$5.62M(+25.8%) | -$10.09M(+125.8%) |
| Mar 2018 | - | -$4.47M | -$4.47M |
| Dec 2017 | -$19.09M(-15.8%) | - | - |
| Dec 2016 | -$22.66M | - | - |
FAQ
- What is TransMedics annual EBITDA?
- What is the all time high annual EBITDA for TransMedics?
- What is TransMedics annual EBITDA year-on-year change?
- What is TransMedics quarterly EBITDA?
- What is the all time high quarterly EBITDA for TransMedics?
- What is TransMedics quarterly EBITDA year-on-year change?
- What is TransMedics TTM EBITDA?
- What is the all time high TTM EBITDA for TransMedics?
- What is TransMedics TTM EBITDA year-on-year change?
What is TransMedics annual EBITDA?
The current annual EBITDA of TMDX is $69.95M
What is the all time high annual EBITDA for TransMedics?
TransMedics all-time high annual EBITDA is $69.95M
What is TransMedics annual EBITDA year-on-year change?
Over the past year, TMDX annual EBITDA has changed by +$77.65M (+1008.05%)
What is TransMedics quarterly EBITDA?
The current quarterly EBITDA of TMDX is $36.27M
What is the all time high quarterly EBITDA for TransMedics?
TransMedics all-time high quarterly EBITDA is $36.27M
What is TransMedics quarterly EBITDA year-on-year change?
Over the past year, TMDX quarterly EBITDA has changed by +$15.98M (+78.75%)
What is TransMedics TTM EBITDA?
The current TTM EBITDA of TMDX is $85.93M
What is the all time high TTM EBITDA for TransMedics?
TransMedics all-time high TTM EBITDA is $85.93M
What is TransMedics TTM EBITDA year-on-year change?
Over the past year, TMDX TTM EBITDA has changed by +$73.09M (+569.38%)